Cognition Corporation Raises $6,000,000 to Accelerate Product Development and Customer Expansion in the Life Science Industry

iCrowdNewswire

Sep 26, 2023

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs.

Lexington, MA – September 26, 2023 – Cognition Corporation, the leader in SaaS-based product development and compliance solutions for the life science industry, today announced $6 million in funding, with a $5 million investment by Spring Lake Equity Partners which follows a $1 million investment by members of Cognition’s management team. The funding will be used to accelerate product development as well as increase sales and marketing programs to support Cognition’s rapid growth.

Cognition is shifting the data management landscape for medical device and pharmaceutical product development from a static, document centric approach to a dynamic, information-based data driven approach. Our solutions automate processes with built-in templates and work instructions. We leverage a structured data environment, that enables our customers to easily build relevant connections between data items, automatically create complex trace matrices, and export formatted documents instantly for regulatory submissions – saving both time and money.

“We are excited to secure this funding that will enable us to both accelerate product development and expand our customer base, and in the process help our customers save time and costs while bringing safer products to market faster,” said Gerald Wesel, Chairman and CEO, Cognition Corporation. “Spring Lake Equity Partners shares our vision for a new “structured data” paradigm for life sciences companies and recognizes Cognition’s potential as the leader in this space.”

“Cognition is well positioned to capture a significant portion of the market with their SaaS-based product development solutions. Their solutions leveraging structured data are unmatched in the industry and will change the way life science companies manage and submit their product development data,” said Bob Forlenza, Managing Partner, Spring Lake Equity Partners. “We are excited to partner with Gerald and the entire team at Cognition to achieve the company’s strategic goals.”

For more information about Cognition’s SaaS solutions for life science product development data, visit www.cognition.us.

For more information about Spring Lake Equity Partners visit https://springlep.com

About Cognition

Cognition Corporation specializes in product development and compliance solutions for the life sciences industries. For medical device professionals, Cognition offers a design controls software platform that helps meet regulations faster with real-time traceability, guided design controls, and change once, update everywhere functionality – turning manual and disconnected data into structured submissions that enable them to get to market faster.

Unlike other design controls solutions that simply replicate traditional documents and spreadsheets, Cognition takes a structured data approach combining risk with test and requirements data so you can easily build relevant connections between data items, automatically create complex trace matrices, and export formatted documents instantly – offering a more efficient and integrated solution.

We are shifting the data management landscape for medical device and pharmaceutical product development from a static, document-based approach to a dynamic, information-driven approach helping to streamline and alleviate the administrative burden of product development documentation. Further information about Cognition Corporation can be found at www.cognition.us.

About Spring Lake Equity Partners

Spring Lake Equity Partners is a Boston based firm investing in private technology companies. We seek to partner with great management teams to take their businesses to the next level, creating value for all stakeholders. Spring Lake strives to add value to our portfolio companies through active board participation, strategic planning, and accessing our network of contacts. To learn more please visit www.springlep.com.

Media Contact
Kristen Callahan
Director of Marketing
Cognition Corporation
+1 (781) 253 – 3388
kristen.callahan@cognition.us

YOU MAY ALSO LIKE

Craig A. Fox joins SEDA Experts’ Energy…

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs. Lexington, MA – September 26,…

read more

Direct Selling Self-Regulatory Council Refers Olive Tree…

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs. Lexington, MA – September 26,…

read more

Kindergarten Teacher Files Federal Lawsuit Against Oakland,…

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs. Lexington, MA – September 26,…

read more

Cognition Corporation Raises $6,000,000 to Accelerate Product Development and Customer Expansion in the Life Science Industry

Nexis Newswire

Sep 26, 2023

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs.

Lexington, MA – September 26, 2023 – Cognition Corporation, the leader in SaaS-based product development and compliance solutions for the life science industry, today announced $6 million in funding, with a $5 million investment by Spring Lake Equity Partners which follows a $1 million investment by members of Cognition’s management team. The funding will be used to accelerate product development as well as increase sales and marketing programs to support Cognition’s rapid growth.

Cognition is shifting the data management landscape for medical device and pharmaceutical product development from a static, document centric approach to a dynamic, information-based data driven approach. Our solutions automate processes with built-in templates and work instructions. We leverage a structured data environment, that enables our customers to easily build relevant connections between data items, automatically create complex trace matrices, and export formatted documents instantly for regulatory submissions – saving both time and money.

“We are excited to secure this funding that will enable us to both accelerate product development and expand our customer base, and in the process help our customers save time and costs while bringing safer products to market faster,” said Gerald Wesel, Chairman and CEO, Cognition Corporation. “Spring Lake Equity Partners shares our vision for a new “structured data” paradigm for life sciences companies and recognizes Cognition’s potential as the leader in this space.”

“Cognition is well positioned to capture a significant portion of the market with their SaaS-based product development solutions. Their solutions leveraging structured data are unmatched in the industry and will change the way life science companies manage and submit their product development data,” said Bob Forlenza, Managing Partner, Spring Lake Equity Partners. “We are excited to partner with Gerald and the entire team at Cognition to achieve the company’s strategic goals.”

For more information about Cognition’s SaaS solutions for life science product development data, visit www.cognition.us.

For more information about Spring Lake Equity Partners visit https://springlep.com

About Cognition

Cognition Corporation specializes in product development and compliance solutions for the life sciences industries. For medical device professionals, Cognition offers a design controls software platform that helps meet regulations faster with real-time traceability, guided design controls, and change once, update everywhere functionality – turning manual and disconnected data into structured submissions that enable them to get to market faster.

Unlike other design controls solutions that simply replicate traditional documents and spreadsheets, Cognition takes a structured data approach combining risk with test and requirements data so you can easily build relevant connections between data items, automatically create complex trace matrices, and export formatted documents instantly – offering a more efficient and integrated solution.

We are shifting the data management landscape for medical device and pharmaceutical product development from a static, document-based approach to a dynamic, information-driven approach helping to streamline and alleviate the administrative burden of product development documentation. Further information about Cognition Corporation can be found at www.cognition.us.

About Spring Lake Equity Partners

Spring Lake Equity Partners is a Boston based firm investing in private technology companies. We seek to partner with great management teams to take their businesses to the next level, creating value for all stakeholders. Spring Lake strives to add value to our portfolio companies through active board participation, strategic planning, and accessing our network of contacts. To learn more please visit www.springlep.com.

Media Contact
Kristen Callahan
Director of Marketing
Cognition Corporation
+1 (781) 253 – 3388
kristen.callahan@cognition.us

Click Here to Visit Our Website

YOU MAY ALSO LIKE

National Advertising Division Refers Shuye Technology “Fastest”…

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs. Lexington, MA – September 26,…

read more

Direct Selling Self-Regulatory Council Refers Olive Tree…

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs. Lexington, MA – September 26,…

read more

In National Advertising Division Fast-Track SWIFT Challenge,…

Cognition’s continued growth enables medical device and pharmaceutical companies to bring safer products to market, while reducing time and costs. Lexington, MA – September 26,…

read more